Breast Carcinoma Clinical Trials Breast Carcinoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Conditions:   Breast Cancer;   Early-stage Breast Cancer;   High Risk Breast Carcinoma Interventions:   Drug: Abemaciclib;   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: LHRH Agonist Sponsors:   Dana-Farber Cancer Institute;   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Conditions:   Breast Cancer Female;   Lobular Breast Carcinoma;   PET/MRI;   Axillary Staging;   Luminal A Breast Cancer Interventions:   Drug: FES;   Procedure: PET/MRI A;   Procedure: PET/MRI B;   Procedure: PET/MRI C;   Procedure: PET/MRI D;   Genetic: Translational analysis Sponsors:   IRCCS San Raffaele;   Associazione Italiana per la Ricerca sul Cancro Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Conditions:   Breast Cancer Female;   Lobular Breast Carcinoma;   PET/MRI;   Axillary Lymphadenopathy;   Luminal A Breast Cancer Interventions:   Drug: FES;   Procedure: PET/MRI A;   Procedure: PET/MRI B;   Procedure: PET/MRI C;   Procedure: PET/MRI D;   Genetic: Translational analysis Sponsors:   Università Vita-Salute San Raffaele;   Associazione Italiana per la Ricerca sul Cancro;   IRCCS San Raffaele Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials